Press Releases

Press Releases

Date Title  
Jan 30, 2018
REDWOOD CITY, Calif. , Jan. 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the Company will effect a 1-for-40 reverse stock split of the Company's common stock, which will be effective
Jan 19, 2018
REDWOOD CITY, Calif. , Jan. 19, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that the Company has received formal notification that the Nasdaq Hearings Panel (the “Panel”) has granted the
Jan 03, 2018
Seven patients successfully treated using next generation image-guided atherectomy device for treatment of peripheral artery disease REDWOOD CITY, Calif. , Jan. 03, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease